Ting Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ting Li has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Catherine Rosa Dufour
Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Canada
56 shared publications - Lingwei Han
Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada
56 shared publications - Vincent Giguère
Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Canada
56 shared publications - Hui Xia
Goodman Cancer Institute, McGill University, Montreal, Canada
55 shared publications - Yonghong Chen
Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada
55 shared publications - Jin-Jian Lu
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR 999078, China
22 shared publications
Latest Publications
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Table 1. RNA-seq analysis of LNCaP HOXB13 KD cells rescued with HOXB13 WT, HOXB13 phospho-deficient mutant 3A, or empty vector (EV) control ± R1881 for 24h.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Table 1. RNA-seq analysis of LNCaP HOXB13 KD cells rescued with HOXB13 WT, HOXB13 phospho-deficient mutant 3A, or empty vector (EV) control ± R1881 for 24h.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Table 2. RNA-seq analysis of LNCaP mTOR KD cells rescued with mTOR or empty vector (EV) control ± R1881 for 24h.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Table 2. RNA-seq analysis of LNCaP mTOR KD cells rescued with mTOR or empty vector (EV) control ± R1881 for 24h.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 4. Androgen response dependency on HOXB13 phosphorylation.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 4. Androgen response dependency on HOXB13 phosphorylation.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 6 (Panels 1-11). Uncropped blots.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 6 (Panels 1-11). Uncropped blots.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Table 4. Source data.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Table 4. Source data.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 1. mTOR negatively regulates HOXB13 protein stability
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 1. mTOR negatively regulates HOXB13 protein stability
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 2. HOXB13 additional phosphorylation at S31 is still dependent on mTOR activity.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 2. HOXB13 additional phosphorylation at S31 is still dependent on mTOR activity.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 5. HOXB13 transcriptional activity depends on its phosphorylation status.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 5. HOXB13 transcriptional activity depends on its phosphorylation status.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Table 3. List of reagents, plasmids, antibodies, and human RT-qPCR primers used in this study.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Table 3. List of reagents, plasmids, antibodies, and human RT-qPCR primers used in this study.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 3. SKP2 is an E3 ligase for HOXB13.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
Supplementary Figure 3. SKP2 is an E3 ligase for HOXB13.